Orszag Peter Richard's Form 4 filing
Lazard, Inc.LAZ · filed Mar 17, 2025
- Accession no.
- 0001628280-25-013284
- Filed
- Mar 17, 2025
- Trade date
- Mar 13-17, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $5.86M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Orszag Peter RichardCIK 0001837678 | Director, Officer (CEO & Chairman) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2025 | Common Stock | MOption exerciseAcquired | +258,154 | –F1 | – | 376,809 | Direct | |
| Mar 13, 2025 | Common Stock | DReturned to the companyDisposed | −77,446 | $45.09F4 | −$3,492,040.14 | 299,363 | Direct | |
| Mar 14, 2025 | Common Stock | SSaleDisposed | −27,208 | $44.87F6 | −$1,220,822.96 | 272,155 | Direct | |
| Mar 14, 2025 | Common Stock | SSaleDisposed | −37,331 | $45.51F7 | −$1,698,933.81 | 234,824 | Direct | |
| Mar 17, 2025 | Common Stock | SSaleDisposed | −38,187 | $45.31F8 | −$1,730,252.97 | 196,637 | Direct | |
| Mar 17, 2025 | Common Stock | SSaleDisposed | −26,352 | $45.91F9 | −$1,209,820.32 | 170,285 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Shares of Common Stock were acquired upon the exchange of the Performance-based Restricted Participation Units ("PRPUs") referenced in Footnote (10).
Referenced by the price of 1 transaction in Table I.
- F4
Represents the average of the high and low price of Common Stock on the New York Stock Exchange on the date of the exchange of the PRPUs referenced in Footnote (10).
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on March 14, 2025 in trades with average execution prices ranging from $44.31 to $45.31 inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on March 14, 2025 in trades with average execution prices ranging from $45.32 to $45.87 inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on March 17, 2025 in trades with average execution prices ranging from $44.80 to $45.80, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report.
Referenced by the price of 1 transaction in Table I.
- F9
The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on March 17, 2025 in trades with average execution prices ranging from $45.81 to $46.11, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report.
Referenced by the price of 1 transaction in Table I.
- F11
Each PRPU (the performance and other conditions of which have been satisfied) represents an interest in Lazard Group LLC that may be exchanged for one share of Common Stock.
Referenced by the price of 1 transaction in Table II.
- F14
Each RPU represents an interest in Lazard Group LLC that has satisfied its minimum value condition and that may be exchanged for one share of Common Stock.
Referenced by the price of 1 transaction in Table II.